SCHEMBL22927642

SCHEMBL22927642

COC(=O)c1ccc(C(=O)c2ccccc2)c(Cl)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.55
RAB9A P51151 5/20 0.54
MAPT P10636 5/20 0.54
KMT2A Q03164 3/20 0.53
MAPK13 O15264 1/20 0.50
MAPK12 P53778 1/20 0.50
MAPK11 Q15759 1/20 0.50
MAPK14 Q16539 1/20 0.50
SRD5A2 P31213 1/20 0.50
CYP1A2 P05177 3/20 0.49
CYP2C19 P33261 3/20 0.49
ALDH1A1 P00352 4/20 0.49
KDM4E B2RXH2 4/20 0.49
HPGD P15428 3/20 0.49
GAA P10253 3/20 0.49
GLA P06280 2/20 0.49
ATM Q13315 2/20 0.49
HSD17B10 Q99714 2/20 0.49
CASP1 P29466 1/20 0.49
CASP7 P55210 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8443482 0.84 TSHR (0.58) TSHRRAB9AMAPTCYP1A2CYP2C19
SCHEMBL1017792 0.83 KDM4E (0.54) TSHRRAB9AMAPTKMT2ACYP1A2
SCHEMBL27904103 0.83 SRD5A2 (0.64) RAB9AMAPTKMT2AMAPK13MAPK12
SCHEMBL69263 0.83 KDM4E (0.62) RAB9AMAPTKMT2ACYP1A2CYP2C19
SCHEMBL28714550 0.82 KDM4E (0.68) TSHRRAB9AMAPTKMT2AMAPK13
SCHEMBL6238741 0.80 ALDH1A1 (0.54) TSHRRAB9AMAPTKMT2ACYP1A2
SCHEMBL2496347 0.80 ALDH1A1 (0.57) TSHRRAB9AMAPTKMT2ACYP1A2
SCHEMBL28719962 0.80 KDM4E (0.66) TSHRRAB9AMAPTKMT2AMAPK13
SCHEMBL28464953 0.80 MAPT (0.52) RAB9AMAPTKMT2ASRD5A2CYP1A2
SCHEMBL27983727 0.79 HTT (0.69) TSHRRAB9AMAPTKMT2ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220289728-A1 MODULATORS OF TREX1 CONSTELLATION PHARMACEUTICALS INC (US) 2022-09-15 US disclosed
EP-4003985-A1 MODULATORS OF TREX1 Constellation Pharmaceuticals, Inc. (US) 2022-06-01 EP disclosed
CN-114174290-A Modulators of TREX1 星座制药公司 2022-03-11 CN disclosed
WO-2021016317-A1 MODULATORS OF TREX1 CONSTELLATION PHARMACEUTICALS, INC. (US) 2021-01-28 WO disclosed
WO-2021016317-A1 MODULATORS OF TREX1 CONSTELLATION PHARMACEUTICALS, INC. (US) 2021-01-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220289728-A1 MODULATORS OF TREX1 CFTR, SLC10A1, CYP27A1 TSHR 1272/4885RAB9A 1079/4885MAPT 2221/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.